What Тетурам Treats: Main Uses and Benefits

The primary role of Тетурам (Disulfiram) is to provide supportive relief for patients managing chronic alcoholism and Alcohol Use Disorder (AUD). Its use is focused strictly on achieving and maintaining long-term abstinence, thereby addressing the core behavioral pattern of relapse. Disulfiram is used to treat chronic alcoholism by providing a pharmacological barrier.

The medication is commonly used across conditions presenting with acute episodes of consumption and is relevant for managing symptoms that interfere with daily comfort. This therapeutic application is typically for chronic alcohol dependence, supporting patients in the high-risk scenario of impulsive alcohol consumption and the behavioral cycle of relapse. It is applied in clinical settings that involve unstable symptom patterns, generally helping to maintain a sense of stability when symptoms are more noticeable.

Therapeutic Support and Patient Benefit

Тетурам is considered relevant for patients with moderate to severe AUD who are part of structured recovery programs. Used as an adjunct to counseling and therapy, its presence may assist with maintaining functional stability, providing a pharmacological deterrent that supports the goal of sobriety. This usage is considered relevant in clinical settings to support the patient during episodes of heightened discomfort, allowing focus on the behavioral aspects of long-term recovery.

Quick Fact: Relief for Chronic Dependence
Provides a pharmacological barrier to support the maintenance of sustained abstinence in patients with chronic AUD.

Regulatory References

1. Disulfiram: MedlinePlus Drug Information

Тетурам (disulfiram) is used in the management of chronic alcohol dependence and is generally safe for patients without certain pre-existing medical conditions.

Who Can Use Тетурам?

It is prescribed to adult patients who have achieved abstinence from alcohol and are committed to maintaining sobriety. Patients must be fully aware of the severe reaction that occurs if alcohol is consumed while taking the medication. The first dose must not be taken until the patient has abstained from alcohol for at least 12 hours.

---

Contraindications and Cautions

Тетурам is not suitable for everyone. It is strictly contraindicated in patients who are:

• In a state of alcohol intoxication.
• Hypersensitive or allergic to disulfiram or other thiuram derivatives (used in pesticides or rubber vulcanization).
• Currently taking metronidazole or paraldehyde.

Use of the medication is also not recommended or requires extreme caution and careful monitoring by a healthcare provider if the patient has:

• Severe heart disease (including severe myocardial disease or uncompensated heart failure).
• Severe liver disease or significant hepatic impairment.
• A history of psychosis or other severe mental illness.
• Brain damage or epilepsy/seizure disorder.
• Kidney disease, diabetes, or an underactive thyroid.

It is generally not recommended for use in pregnancy due to a lack of established safety data, and the potential benefits must clearly outweigh the risks.

Interactions with other medicines and products

Teturam (Disulfiram) has several clinically significant interactions that are strictly documented in regulatory information.

Interaction Type	Interacting Substance/Class	Key Regulatory Constraint
Contraindicated	Alcohol/Ethanol	Must not be administered until the patient has abstained from alcohol for at least 12 hours. Alcohol must be avoided for a minimum of 14 days after the last dose due to the severe Disulfiram-Ethanol reaction.
Contraindicated	Metronidazole	Concomitant use is prohibited due to the risk of acute psychosis and confusional states.
Pharmacokinetic	Oral Anticoagulants (e.g., Warfarin)	Disulfiram inhibits the metabolism of the anticoagulant, requiring close monitoring of Prothrombin Time and potential dose adjustment to avoid bleeding risk.
Pharmacokinetic	Phenytoin	Disulfiram decreases the metabolism of phenytoin, leading to increased plasma concentrations and potential toxicity. Blood level monitoring is required.
Pharmacokinetic	Theophylline	Inhibition of metabolism results in elevated serum levels of theophylline, requiring careful monitoring and possible dose reduction.
Pharmacodynamic	Isoniazid	Concomitant use has been associated with reports of changes in mental state, incoordination, and unsteady gait.

Disulfiram's interaction profile is primarily defined by its inhibitory effect on Aldehyde Dehydrogenase and its influence on the clearance of several major medicinal agents via hepatic enzyme inhibition.

Irreversible Blockade of Alcohol Metabolism

This core mechanism involves the drug's active metabolite forming a covalent, permanent bond with the enzyme Aldehyde Dehydrogenase (ALDH), permanently blocking the primary pathway for the oxidation of ethanol's first metabolite. This metabolic interference ensures that upon any alcohol intake, the poisonous intermediate, acetaldehyde, rapidly accumulates in the blood and tissues, determining the predictable physiological outcome.

---

Cascade of Acetaldehyde Accumulation and Systemic Reaction

The high concentration of accumulated acetaldehyde acts as a circulating toxin, triggering the release of vasoactive mediators such as histamine, leading to widespread systemic vasodilation and a subsequent drop in blood pressure (hypotension). This acute systemic physiological response, amplified by the inhibition of the secondary enzyme Dopamine beta-Hydroxylase (DbetaH) which modulates vascular tone, constitutes the expected systemic consequence of the enzyme blockade. The irreversible nature of the inhibition dictates the persistence of the enzyme blockade until the synthesis of new ALDH occurs, typically spanning one to two weeks.

Official Administration and Dosing Guidelines

Тетурам (Disulfiram) is administered orally as a tablet. The medication follows a standardized two-phase regimen: an initial induction period and a long-term maintenance phase. Its use must not commence until the patient has achieved sobriety for at least 12 hours.

Instruction	Detail
Route of administration	Oral (tablet)
Dosing schedule	Initial: 500 mg once daily for one to two weeks. Maintenance: 250 mg once daily (range 125 mg to 500 mg). Maximum: 500 mg daily.
Frequency pattern	Once daily (uninterrupted administration)
Timing in relation to meals	May be taken with or without food.

For administration, the tablet can be taken at any time, though patients experiencing a sedative effect may take it at bedtime. The tablet is also described as suitable for being crushed and mixed with liquids, such as water, coffee, or juice, to aid consumption. The treatment is typically long-term, continuing for months or years until a stable basis for self-control has been established.

Population-Specific Use

Caution is generally advised for dosage selection in older patients, often suggesting starting at the lower end of the maintenance range. Use in pediatric patients (under 18 years of age) is not recommended as safety and effectiveness are not established in this population.

Research evidence / Overview of studies for Тетурам (Disulfiram)

Evidence for Use in Chronic Alcohol Use Disorder (AUD)

Research examining Disulfiram for chronic Alcohol Use Disorder was studied for its use as a potential deterrent alongside support for abstinence. A large body of evidence, including Randomized Controlled Trials (RCTs) and systematic reviews, was studied for this indication in adults with chronic alcohol dependence who are motivated to stop drinking.

These studies monitored several key outcomes reflecting daily functioning or activity level, such as the rate of continuous abstinence and the time to first lapse or relapse or drinking episode. Researchers also tracked overall alcohol consumption and the number of days of drinking recorded during the study period. Findings describe patterns observed in the studies related to abstinence-related measurements. For example, some trials reported a difference in the proportion of patients who achieved abstinence between the Disulfiram groups and control groups. However, the overall evidence quality varies across studies, and results are not uniform across all trial designs.

---

The Role of Study Design: Supervised vs. Unsupervised Research

The evidence base for Disulfiram is characterized by a distinction in findings based on how the medicine was observed in the research. Studies explored the use of the medicine in both supervised and unsupervised settings. Supervised use refers to research where a third party, such as a family member or clinician, confirmed the medication was taken.

Research describes patterns showing that measurements related to alcohol consumption and abstinence were observed in some studies that featured supervised drug administration. Conversely, trials designed to be blinded, or those relying on unsupervised use, often reported data that showed limited separation between the study groups, indicating that the method of administration was monitored as a critical variable in the research findings.

---

What is Still Uncertain About Тетурам: Evidence Gaps and Inconsistency

Current evidence contributes to the broader evidence landscape, but it also highlights important research limitations. The most prominent uncertainty stems from the inconsistency of findings between controlled, blinded trials and open-label, supervised trials. Furthermore, long-term effects are not fully established, and comparative evidence is lacking in some areas to definitively understand how Disulfiram compares to other treatments over extended periods. The research provides context but not individual predictions.

Key Studies & References

1. Disulfiram: MedlinePlus Drug Information

Common questions about Тетурам (FAQ)

Q: What is Тетурам used for?

A: Тетурам (disulfiram) is a medicine used to treat chronic alcoholism. It works by blocking the breakdown of alcohol in the body, which leads to unpleasant, severe side effects when even a small amount of alcohol is consumed. This helps discourage people from drinking alcohol. It is used as part of a complete treatment program that includes counseling and medical supervision.

---

Q: How does Тетурам make you feel sick if you drink alcohol?

A: When you drink alcohol, your body normally breaks it down into a substance called acetaldehyde, and then further into harmless compounds. Тетурам stops the body from breaking down acetaldehyde. This causes acetaldehyde levels to quickly build up in the blood. This buildup is what causes the very unpleasant and potentially dangerous reactions, often called the disulfiram-alcohol reaction.

---

Q: What are the symptoms of a disulfiram-alcohol reaction?

A: The symptoms of a disulfiram-alcohol reaction can be severe and dangerous. They may begin within minutes of consuming alcohol and can last for several hours. Common symptoms include flushing (redness and warmth of the skin), a throbbing headache, dizziness, nausea, vomiting, sweating, chest pain, difficulty breathing, fast or pounding heartbeat, and significant anxiety. In severe cases, the reaction can lead to fainting, seizures, and even death. It is essential to avoid all forms of alcohol while taking Тетурам.

---

Q: How long after stopping Тетурам do I need to avoid alcohol?

A: You must continue to avoid alcohol for up to 14 days (two weeks) after you stop taking Тетурам. This is because the effects of the medicine can last for this period. If you drink alcohol during this time, you can still experience the severe and potentially life-threatening disulfiram-alcohol reaction.

---

Q: Does Тетурам interact with other medicines?

A: Yes, Тетурам can interact with many other medicines. It is important to tell your doctor or pharmacist about all prescription and non-prescription medicines, vitamins, and herbal products you are currently taking. Some notable interactions include certain blood thinners (like warfarin), phenytoin, and isoniazid, as Тетурам can affect how your body processes these drugs.

---

Q: Can I take Тетурам if I am pregnant or breastfeeding?

A: Тетурам is generally not recommended for use during pregnancy or while breastfeeding. If you are pregnant, planning to become pregnant, or breastfeeding, you must discuss this with your doctor. They will weigh the potential benefits of the medication against the potential risks to the baby. Your doctor will determine the safest treatment plan for you.

Storage and Disposal of Disulfiram (Teturam) Tablets

---

Storage Requirements

Disulfiram tablets must be stored at Controlled Room Temperature (CRT), maintaining a range between 20 C and 25 C ( 68 F to 77 F). The container must be kept tightly closed in its original packaging and stored away from excess heat, moisture, and direct light. It is mandatory to keep the medicine out of the sight and reach of children and to keep it from freezing.

Disposal Instructions

Expired or unused tablets must be properly discarded. The preferred disposal method is through an authorized drug take-back program. If a program is unavailable, the medicine should be mixed with an unappealing substance, sealed in a container, and placed in the household trash. Do not flush the tablets down the toilet or pour them into any drain.